Richard D Maradiaga

Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target

S. Millis, James L. Chen, H. Katzenstein, 2021, npj Precision Oncology.